Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment
Author:
Affiliation:
1. CRCINA, INSERM, CNRS, Université de Nantes, Université d’Angers, Nantes, France;
2. GDR3697 Micronit, CNRS, Nantes, France;
3. Service d’hématologie clinique, CHU de Nantes, Nantes, France
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1357177
Reference72 articles.
1. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
2. Mantle Cell Lymphoma: A Clinicopathologic Study of 80 Cases
3. Molecular pathogenesis of mantle cell lymphoma
4. High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
5. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis;Blood Advances;2024-08-29
2. CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression;Blood Advances;2024-08-16
3. Anlotinib Inhibiting Mantle Cell Lymphoma Proliferation and Inducing Apoptosis through PI3K/AKT/mTOR Pathway;Current Molecular Medicine;2024-04-24
4. Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey;Annals of Hematology;2024-04-17
5. A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses;Leukemia;2023-04-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3